To further advance research on the role of DYRK1A in dementia and cognition in DS, there is a clear need to have access to tool compounds that are highly active and highly selective against DYRK1A, while simultaneously being compatible with the requirements of animal models. Here, DYRK1A is linked to Dravet syndrome.